SCHAUB JAMES (EVP and COO) purchased 38.5% of their position (150K shares) of RVL PHARMACEUTICALS PLC on the open market
Open‑market purchase worth $232.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/9/2022ACC: 0001104659-22-088038
Officer· EVP and COO
Since Oct 2018
+150K
Net shares
Net buyer
$232.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+150K
Price / share
$1.55
Trade value
$232.50K
% of position
38.5%
8/8/2022
390.02K→540.02K
Total
Net shares
+150K
Net value
$232.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/8/2022 | P · Purchase | +150K | $1.55 | $232.50K | 38.5% | 390.02K | 540.02K |
| Total | +150K | $232.50K | ||||||
Derivative Transactions0
No derivative transactions reported